|
Administration of Nootropic Agents for Enhancing Neuroprotective Signaling in Parkinson’s Disease
Background
Parkinson’s Disease (PD) is a chronic, neurodegenerative disease, caused by the progressive loss of midbrain dopamine neurons in the substantia nigra, which sends axons to the striatum. Approximately 1% of Americans are afflicted with PD, which give rise to more than $14 billion in medical-related costs each year. Symptoms include...
Published: 10/14/2024
|
Inventor(s): Raul Dagda, Ruben Dagda
Keywords(s): Life Sciences
Category(s): Technology Classifications > Life Sciences
|
